ThermoGenesis Holdings Stock Analysis & Ratings
THMO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.09 - $2.50
Previous Close$0.23
Volume2.89M
Average Volume (3M)2.70M
Market CapN/A
Enterprise ValueN/A
P/E Ratio-0.2
Beta1.70
Next EarningsAug 17, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
THMO FAQ
What was ThermoGenesis Holdings’s price range in the past 12 months?
ThermoGenesis Holdings lowest stock price was $0.09 and its highest was $2.50 in the past 12 months.
What is ThermoGenesis Holdings’s market cap?
Currently, no data Available
What is ThermoGenesis Holdings’s price target?
Currently, no data Available
What do analysts say about ThermoGenesis Holdings?
Not enough analysts have published a price target to provide an average price target.
When is ThermoGenesis Holdings’s upcoming earnings report date?
ThermoGenesis Holdings’s upcoming earnings report date is Aug 17, 2022 which is in 9 days.
How were ThermoGenesis Holdings’s earnings last quarter?
ThermoGenesis Holdings released its earnings results on May 19, 2022. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.16.
Is ThermoGenesis Holdings overvalued?
According to Wall Street analysts ThermoGenesis Holdings’s price is currently Overvalued.
Does ThermoGenesis Holdings pay dividends?
ThermoGenesis Holdings does not currently pay dividends.
What is ThermoGenesis Holdings’s EPS estimate?
ThermoGenesis Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ThermoGenesis Holdings have?
ThermoGenesis Holdings has 31,321,362 shares outstanding.
What happened to ThermoGenesis Holdings’s price movement after its last earnings report?
ThermoGenesis Holdings reported an EPS of -$0.16 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.526%.
Which hedge fund is a major shareholder of ThermoGenesis Holdings?
Currently, no hedge funds are holding shares in THMO
---
ThermoGenesis Holdings Stock Analysis
Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Price Target
No data currently available
Analyst Forecast
N/A
Currently Not Enough Data Available
Blogger Sentiment
N/A
Currently Not Enough Data Available
Hedge Fund Holdings
N/A
Currently Not Enough Data Available
Insider Transactions
▲ Bought Shares
Worth $3.0M over the Last 3 Months
Retail Investors
Very Positive
Last 7 Days ▼ 1.0% Last 30 Days ▲ 13.3%
News Sentiment
Neutral
Bullish 50% Bearish 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.46%
12-Months-Change
Fundamentals
Return on Equity
-176.62%
Trailing 12-Months
Asset Growth
-22.52%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ThermoGenesis Holdings
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine. It operates through the following segments: Device and Clinical Development. The Device segment includes development and commercialization of automated systems that provide good manufacturing practice, clinical grade cell-banking, cell-processing and cell-based therapeutics. The Clinical Development segment develops autologous stem cell-based therapeutics that address significant unmet medical needs for the vascular, cardiology, and orthopedic markets. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
---
---